MACQUARIE GROUP LTD - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$40,952,000
-42.0%
1,076,548
+38.8%
0.05%
-37.0%
Q2 2023$70,646,000
-24.1%
775,480
-45.1%
0.08%
-27.0%
Q1 2023$93,101,000
+23.2%
1,411,479
-3.4%
0.11%
+24.7%
Q4 2022$75,582,000
-22.2%
1,461,642
+2.8%
0.09%
-25.2%
Q3 2022$97,182,000
+55.3%
1,421,535
+2.7%
0.12%
+70.0%
Q2 2022$62,562,000
-6.8%
1,383,507
+4.7%
0.07%
+37.3%
Q1 2022$67,149,000
+9.9%
1,321,558
+2.3%
0.05%0.0%
Q4 2021$61,075,000
+65.4%
1,291,783
+15.3%
0.05%
+64.5%
Q3 2021$36,918,000
+7.0%
1,120,090
+105.3%
0.03%
+10.7%
Q2 2021$34,487,000
+37385.9%
545,674
+25339.3%
0.03%
Q1 2021$92,000
-43.9%
2,145
-25.1%
0.00%
Q4 2020$164,000
+90.7%
2,8620.0%0.00%
Q3 2020$86,000
-7.5%
2,8620.0%0.00%
Q2 2020$93,0002,8620.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders